AXP
74
3
UNM
59
3
REGN
57
2
HCA
64
4
ADBE
56
4
OI
54
-9
FFIV
55
5
LLY
62
2
L
67
4
WMB
51
3
LH
55
5
CMA
75
2
CHD
34
2
RCL
73
8
KMI
59
6
UNH
36
3
F
62
2
MU
68
-3
TGT
56
3
WY
54
4
AXP
74
3
UNM
59
3
REGN
57
2
HCA
64
4
ADBE
56
4
OI
54
-9
FFIV
55
5
LLY
62
2
L
67
4
WMB
51
3
LH
55
5
CMA
75
2
CHD
34
2
RCL
73
8
KMI
59
6
UNH
36
3
F
62
2
MU
68
-3
TGT
56
3
WY
54
4
Financhill
Back

Fair Isaac Corp. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
74

FICO
Fair Isaac Corp.

Last Price:
$1,827.23
Seasonality Move:
8.54%
Sell
33

NKTR
Nektar Therapeutics

Last Price:
$51.10
Seasonality Move:
11.58%
Buy
74
Fair Isaac Corp. (FICO) is a Buy

Is Fair Isaac Corp. a Buy, Sell or Hold?

  • The current Fair Isaac Corp. [FICO] share price is $1,825.83. The Score for FICO is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • FICO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FICO Stock Price Chart

What is Fair Isaac Corp.'s stock price today?

  • The Fair Isaac Corp. share price today is $1,825.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FICO is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $51.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

FICO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.53 Buy
Relative Strength Index (14 RSI): 60.37 Buy
Chaikin Money Flow: 194787 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1730.77 - 1796.21) Buy
Bollinger Bands (100): (1439.12 - 1740.62) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -893008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.73 - 61.07) Sell
Bollinger Bands (100): (32.3 - 62.42) Buy

FICO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1775.21 Buy
20-day SMA: 1767.02 Buy
50-day SMA: 1715.71 Buy
200-day SMA: 1710.9 Buy
8-day EMA: 1778.88 Buy
20-day EMA: 1760.78 Buy
50-day EMA: 1708.2 Buy
200-day EMA: 1692.97 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.44 Sell
20-day SMA: 58.08 Sell
50-day SMA: 58.52 Sell
200-day SMA: 30.43 Buy
8-day EMA: 56.58 Sell
20-day EMA: 57.71 Sell
50-day EMA: 55.82 Sell
200-day EMA: 37.69 Buy

Fair Isaac Corp. Earnings Growth & FICO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.75 per share, and an increase next year of $11.40 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Fair Isaac Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):